Key Points Chesapeake sold 9,875 Eli Lilly and Company shares; estimated trade value of approximately $7.68 million, based on the average price for Q2 2025 Transaction represented 6.9% of fund AUM.

U.S. pharmaceutical giant Eli Lilly and Company has announced plans to invest over $1 billion in Telangana, strengthening ...

Independence Bank of Kentucky disclosed a purchase of 4,193 shares of Eli Lilly and Company (NYSE: LLY), estimated at $3.12 ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...

Analysts have set 12-month price targets for Eli Lilly, revealing an average target of $934.09, a high estimate of $1135.00, ...

For many Americans, a trip to the pharmacy means the stresses of figuring out which drugs are covered or how to afford those ...

Eli Lilly stock (NYSE: LLY) should be on your radar. Here’s why – it is presently trading within the support range ($688 – $761), price points from which it has previously bounced significantly. Over ...

The t:slim X2 automated insulin delivery system with Control IQ+ technology. [Image courtesy of Tandem Diabetes Care] Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received approval to ...

President Donald Trump announced on Sept. 25 that the U.S. will impose a 100% tariff on branded or patented pharmaceutical products that enter the country starting Oct 1. But Eli Lilly, one of ...

Eli Lilly’s planned $5-billion biomanufacturing facility in Goochland County, Va., about 20 miles west of downtown Richmond, represents one of the largest private capital investments in state history.